{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:16:34Z","timestamp":1790788594363,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1093\/jac\/dki166","type":"journal-article","created":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T00:14:04Z","timestamp":1117066444000},"page":"52-59","source":"Crossref","is-referenced-by-count":594,"title":["Emergence of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs) in the community"],"prefix":"10.1093","volume":"56","author":[{"given":"Johann D. D.","family":"Pitout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Laupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Poirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,5,25]]},"reference":[{"key":"key\n\t\t\t\t20171012192624_B1","doi-asserted-by":"crossref","unstructured":"Medeiros AA. Evolution and dissemination of \u03b2-lactamases accelerated by generations of \u03b2-lactam antibiotics. Clin Infect Dis1997; 24 Suppl 1: S19\u2013S45.","DOI":"10.1093\/clinids\/24.Supplement_1.S19"},{"key":"key\n\t\t\t\t20171012192624_B2","doi-asserted-by":"crossref","unstructured":"Bush K. New \u03b2-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis2001; 32: 1085\u20139.","DOI":"10.1086\/319610"},{"key":"key\n\t\t\t\t20171012192624_B3","doi-asserted-by":"crossref","unstructured":"Jacoby GA, Munoz-Price LS. The new \u03b2-lactamases. N Engl J Med2005; 352: 380\u201391.","DOI":"10.1056\/NEJMra041359"},{"key":"key\n\t\t\t\t20171012192624_B4","doi-asserted-by":"crossref","unstructured":"Bradford PA. Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev2001; 14: 933\u201351.","DOI":"10.1128\/CMR.14.4.933-951.2001"},{"key":"key\n\t\t\t\t20171012192624_B5","doi-asserted-by":"crossref","unstructured":"Helfand MS, Bonomo RA. \u03b2-Lactamases: a survey of protein diversity. Curr Drug Targets Infect Disord2003; 3: 9\u201323.","DOI":"10.2174\/1568005033342181"},{"key":"key\n\t\t\t\t20171012192624_B6","doi-asserted-by":"crossref","unstructured":"Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis2003; 36: S11\u2013S23.","DOI":"10.1086\/344654"},{"key":"key\n\t\t\t\t20171012192624_B7","doi-asserted-by":"crossref","unstructured":"Paterson DL. Serious infections caused by enteric gram-negative bacilli\u2014mechanisms of antibiotic resistance and implications for therapy of gram-negative sepsis in the transplanted patient. Semin Respir Infect2002; 17: 260\u20134.","DOI":"10.1053\/srin.2002.36446"},{"key":"key\n\t\t\t\t20171012192624_B8","doi-asserted-by":"crossref","unstructured":"Poole K. Resistance to \u03b2-lactam antibiotics. Cell Mol Life Sci2004; 61: 2200\u201323.","DOI":"10.1007\/s00018-004-4060-9"},{"key":"key\n\t\t\t\t20171012192624_B9","doi-asserted-by":"crossref","unstructured":"Ambler RP, Coulson AF, Frere JM et al. A standard numbering scheme for the class A \u03b2-lactamases. Biochem J1991; 276: 269\u201370.","DOI":"10.1042\/bj2760269"},{"key":"key\n\t\t\t\t20171012192624_B10","doi-asserted-by":"crossref","unstructured":"Bonnet R. Growing group of extended-spectrum \u03b2-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother2004; 48: 1\u201314.","DOI":"10.1128\/AAC.48.1.1-14.2004"},{"key":"key\n\t\t\t\t20171012192624_B11","doi-asserted-by":"crossref","unstructured":"Girlich D, Poirel L, Leelaporn A et al. Molecular epidemiology of the integron-located VEB-1 extended-spectrum \u03b2-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol2001; 39: 175\u201382.","DOI":"10.1128\/JCM.39.1.175-182.2001"},{"key":"key\n\t\t\t\t20171012192624_B12","doi-asserted-by":"crossref","unstructured":"Tzelepi E, Magana C, Platsouka E et al. Extended-spectrum \u03b2-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents2003; 21: 285\u20138.","DOI":"10.1016\/S0924-8579(02)00361-8"},{"key":"key\n\t\t\t\t20171012192624_B13","doi-asserted-by":"crossref","unstructured":"Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum \u03b2-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother2003; 47: 2385\u201392.","DOI":"10.1128\/AAC.47.8.2385-2392.2003"},{"key":"key\n\t\t\t\t20171012192624_B14","doi-asserted-by":"crossref","unstructured":"Poirel L, Menuteau O, Agoli N et al. Outbreak of extended-spectrum \u03b2-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol2003; 41: 3542\u20137.","DOI":"10.1128\/JCM.41.8.3542-3547.2003"},{"key":"key\n\t\t\t\t20171012192624_B15","doi-asserted-by":"crossref","unstructured":"Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs). Clin Microbiol Infect2000; 6: 460\u20133.","DOI":"10.1046\/j.1469-0691.2000.00107.x"},{"key":"key\n\t\t\t\t20171012192624_B16","doi-asserted-by":"crossref","unstructured":"Mammeri H, Van De Loo M, Poirel L et al. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother2005; 49: 71\u20136.","DOI":"10.1128\/AAC.49.1.71-76.2005"},{"key":"key\n\t\t\t\t20171012192624_B17","doi-asserted-by":"crossref","unstructured":"Wang M, Sahm DF, Jacoby GA et al. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother2004; 48: 1295\u20139.","DOI":"10.1128\/AAC.48.4.1295-1299.2004"},{"key":"key\n\t\t\t\t20171012192624_B18","doi-asserted-by":"crossref","unstructured":"Kassis-Chikhani N, Vimont S, Asselat K et al. CTX-M \u03b2-lactamase-producing Escherichia coli in long-term care facilities, France. Emerg Infect Dis2004; 10: 1697\u20138.","DOI":"10.3201\/eid1009.030969"},{"key":"key\n\t\t\t\t20171012192624_B19","doi-asserted-by":"crossref","unstructured":"Bradford PA, Urban C, Jaiswal A et al. SHV-7, a novel cefotaxime-hydrolyzing \u03b2-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother1995; 39: 899\u2013905.","DOI":"10.1128\/AAC.39.4.899"},{"key":"key\n\t\t\t\t20171012192624_B20","doi-asserted-by":"crossref","unstructured":"Humeniuk C, Arlet G, Gautier V et al. \u03b2-Lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother2002; 46: 3045\u20139.","DOI":"10.1128\/AAC.46.9.3045-3049.2002"},{"key":"key\n\t\t\t\t20171012192624_B21","doi-asserted-by":"crossref","unstructured":"Poirel L, Kampfer P, Nordmann P. Chromosome-encoded Ambler class A \u03b2-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother2002; 46: 4038\u201340.","DOI":"10.1128\/AAC.46.12.4038-4040.2002"},{"key":"key\n\t\t\t\t20171012192624_B22","doi-asserted-by":"crossref","unstructured":"Decousser JW, Poirel L, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A \u03b2-lactamase from Kluyvera cryocrescens. Antimicrob Agents Chemother2001; 45: 3595\u20138.","DOI":"10.1128\/AAC.45.12.3595-3598.2001"},{"key":"key\n\t\t\t\t20171012192624_B23","doi-asserted-by":"crossref","unstructured":"Rodriguez MM, Power P, Radice M et al. Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: a possible origin of plasmid-borne CTX-M-1-derived cefotaximases. Antimicrob Agents Chemother2004; 48: 4895\u20137.","DOI":"10.1128\/AAC.48.12.4895-4897.2004"},{"key":"key\n\t\t\t\t20171012192624_B24","doi-asserted-by":"crossref","unstructured":"Boyd DA, Olson AB, Silverman M et al. Identification of a progenitor of the CTX-M-9 group of extended-spectrum \u03b2-lactamases from Kluyvera spp. isolated in Guyana. In: Programs and Abstracts of the Forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA, 2004. Abstract C1-1661. American Society for Microbiology, Washington, DC, USA.","DOI":"10.1128\/AAC.49.5.2112-2115.2005"},{"key":"key\n\t\t\t\t20171012192624_B25","doi-asserted-by":"crossref","unstructured":"Bernard H, Tancrede C, Livrelli V et al. A novel plasmid-mediated extended-spectrum \u03b2-lactamase not derived from TEM- or SHV-type enzymes. J Antimicrob Chemother1992; 29: 590\u20132.","DOI":"10.1093\/jac\/29.5.590"},{"key":"key\n\t\t\t\t20171012192624_B26","doi-asserted-by":"crossref","unstructured":"Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol2004; 42: 4769\u201375.","DOI":"10.1128\/JCM.42.10.4769-4775.2004"},{"key":"key\n\t\t\t\t20171012192624_B27","doi-asserted-by":"crossref","unstructured":"Weill FX, Lailler R, Praud K et al. Emergence of extended-spectrum-\u03b2-lactamase (CTX-M-9)-producing multiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J Clin Microbiol2004; 42: 5767\u201373.","DOI":"10.1128\/JCM.42.12.5767-5773.2004"},{"key":"key\n\t\t\t\t20171012192624_B28","doi-asserted-by":"crossref","unstructured":"Karim A, Poirel L, Nagarajan S et al. Plasmid-mediated extended-spectrum \u03b2-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett2001; 201: 237\u201341.","DOI":"10.1111\/j.1574-6968.2001.tb10762.x"},{"key":"key\n\t\t\t\t20171012192624_B29","doi-asserted-by":"crossref","unstructured":"Poirel L, Naas T, Le Thomas I, et al. CTX-M-type extended-spectrum \u03b2-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother2001; 45: 3355\u201361.","DOI":"10.1128\/AAC.45.12.3355-3361.2001"},{"key":"key\n\t\t\t\t20171012192624_B30","doi-asserted-by":"crossref","unstructured":"Thomson KS. Controversies about extended-spectrum and AmpC \u03b2-lactamases. Emerg Infect Dis2001; 7: 333\u20136.","DOI":"10.3201\/eid0702.010238"},{"key":"key\n\t\t\t\t20171012192624_B31","doi-asserted-by":"crossref","unstructured":"Paterson DL, Yu VL. Extended-spectrum \u03b2-lactamases: a call for improved detection and control. Clin Infect Dis1999; 29: 1419\u201322.","DOI":"10.1086\/313559"},{"key":"key\n\t\t\t\t20171012192624_B32","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2005."},{"key":"key\n\t\t\t\t20171012192624_B33","unstructured":"British Society for Antimicrobial Chemotherapy. http:\/\/www.bsac.org.uk. (18 April 2005, date last accessed)."},{"key":"key\n\t\t\t\t20171012192624_B34","doi-asserted-by":"crossref","unstructured":"Hageman JC, Fridkin SK, Mohammed JM et al. Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories. Infect Control Hosp Epidemiol2003; 24: 356\u201361.","DOI":"10.1086\/502214"},{"key":"key\n\t\t\t\t20171012192624_B35","doi-asserted-by":"crossref","unstructured":"Stevenson KB, Samore M, Barbera J et al. Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards. Diagn Microbiol Infect Dis2003; 47: 303\u201311.","DOI":"10.1016\/S0732-8893(03)00092-0"},{"key":"key\n\t\t\t\t20171012192624_B36","doi-asserted-by":"crossref","unstructured":"Steward CD, Wallace D, Hubert SK et al. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories. Diagn Microbiol Infect Dis2000; 38: 59\u201367.","DOI":"10.1016\/S0732-8893(00)00161-9"},{"key":"key\n\t\t\t\t20171012192624_B37","doi-asserted-by":"crossref","unstructured":"Tenover FC, Mohammed MJ, Gorton TS et al. Detection and reporting of organisms producing extended-spectrum \u03b2-lactamases: survey of laboratories in Connecticut. J Clin Microbiol1999; 37: 4065\u201370.","DOI":"10.1128\/JCM.37.12.4065-4070.1999"},{"key":"key\n\t\t\t\t20171012192624_B38","doi-asserted-by":"crossref","unstructured":"Tenover FC, Mohammed MJ, Stelling J et al. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol2001; 39: 241\u201350.","DOI":"10.1128\/JCM.39.1.241-250.2001"},{"key":"key\n\t\t\t\t20171012192624_B39","doi-asserted-by":"crossref","unstructured":"Brenwald NP, Jevons G, Andrews JM et al. An outbreak of a CTX-M-type \u03b2-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum \u03b2-lactamases. J Antimicrob Chemother2003; 51: 195\u20136.","DOI":"10.1093\/jac\/dkg051"},{"key":"key\n\t\t\t\t20171012192624_B40","doi-asserted-by":"crossref","unstructured":"Dandekar PK, Tetreault J, Quinn JP et al. Prevalence of extended spectrum \u03b2-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut. Diagn Microbiol Infect Dis2004; 49: 37\u20139.","DOI":"10.1016\/j.diagmicrobio.2003.11.009"},{"key":"key\n\t\t\t\t20171012192624_B41","doi-asserted-by":"crossref","unstructured":"Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-\u03b2-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol2004; 42: 5715\u201321.","DOI":"10.1128\/JCM.42.12.5715-5721.2004"},{"key":"key\n\t\t\t\t20171012192624_B42","doi-asserted-by":"crossref","unstructured":"Cormican M, Morris D, Corbett-Feeney G et al. Extended spectrum \u03b2-lactamase production and fluoroquinolone resistance in pathogens associated with community acquired urinary tract infection. Diagn Microbiol Infect Dis1998; 32: 317\u20139.","DOI":"10.1016\/S0732-8893(98)00113-8"},{"key":"key\n\t\t\t\t20171012192624_B43","doi-asserted-by":"crossref","unstructured":"Colodner R, Keness Y, Chazan B et al. Antimicrobial susceptibility of community-acquired uropathogens in northern Israel. Int J Antimicrob Agents2001; 18: 189\u201392.","DOI":"10.1016\/S0924-8579(01)00368-5"},{"key":"key\n\t\t\t\t20171012192624_B44","doi-asserted-by":"crossref","unstructured":"Colodner R, Rock W, Chazan B et al. Risk factors for the development of extended-spectrum \u03b2-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis2004; 23: 163\u20137.","DOI":"10.1007\/s10096-003-1084-2"},{"key":"key\n\t\t\t\t20171012192624_B45","doi-asserted-by":"crossref","unstructured":"Bou G, Cartelle M, Tomas M et al. Identification and broad dissemination of the CTX-M-14 \u03b2-lactamase in different Escherichia coli strains in the northwest area of Spain. J Clin Microbiol2002; 40: 4030\u20136.","DOI":"10.1128\/JCM.40.11.4030-4036.2002"},{"key":"key\n\t\t\t\t20171012192624_B46","doi-asserted-by":"crossref","unstructured":"Poirel L, Decousser JW, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M \u03b2-lactamase gene. Antimicrob Agents Chemother2003; 47: 2938\u201345.","DOI":"10.1128\/AAC.47.9.2938-2945.2003"},{"key":"key\n\t\t\t\t20171012192624_B47","doi-asserted-by":"crossref","unstructured":"Arpin C, Dubois V, Coulange L et al. Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother2003; 47: 3506\u201314.","DOI":"10.1128\/AAC.47.11.3506-3514.2003"},{"key":"key\n\t\t\t\t20171012192624_B48","doi-asserted-by":"crossref","unstructured":"Lescure FX, Eveillard M, Douadi Y et al. Community-acquired multiresistant bacteria: an emerging problem? J Hosp Infect2001; 49: 149\u201351.","DOI":"10.1053\/jhin.2000.0910"},{"key":"key\n\t\t\t\t20171012192624_B49","doi-asserted-by":"crossref","unstructured":"Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol2004; 42: 1089\u201394.","DOI":"10.1128\/JCM.42.3.1089-1094.2004"},{"key":"key\n\t\t\t\t20171012192624_B50","doi-asserted-by":"crossref","unstructured":"Pitout JD, Hanson ND, Church DL et al. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum \u03b2-lactamases: importance of community isolates with blaCTX-M genes. Clin Infect Dis2004; 38: 1736\u201341.","DOI":"10.1086\/421094"},{"key":"key\n\t\t\t\t20171012192624_B51","doi-asserted-by":"crossref","unstructured":"Munday CJ, Whitehead GM, Todd NJ et al. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum \u03b2-lactamases in York, UK. J Antimicrob Chemother2004; 54: 628\u201333.","DOI":"10.1093\/jac\/dkh397"},{"key":"key\n\t\t\t\t20171012192624_B52","doi-asserted-by":"crossref","unstructured":"Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum \u03b2-lactamases in the UK. J Antimicrob Chemother2004; 54: 735\u201343.","DOI":"10.1093\/jac\/dkh424"},{"key":"key\n\t\t\t\t20171012192624_B53","doi-asserted-by":"crossref","unstructured":"Prats G, Mirelis B, Miro E et al. Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerg Infect Dis2003; 9: 1273\u201380.","DOI":"10.3201\/eid0910.030179"},{"key":"key\n\t\t\t\t20171012192624_B54","doi-asserted-by":"crossref","unstructured":"Kim S, Kim J, Kang Y et al. Occurrence of extended-spectrum \u03b2-lactamases in members of the genus Shigella in the Republic of Korea. J Clin Microbiol2004; 42: 5264\u20139.","DOI":"10.1128\/JCM.42.11.5264-5269.2004"},{"key":"key\n\t\t\t\t20171012192624_B55","doi-asserted-by":"crossref","unstructured":"Brigante G, Luzzaro F, Perilli M et al. Evolution of CTX-M-type \u03b2-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents2005; 25: 157\u201362.","DOI":"10.1016\/j.ijantimicag.2004.09.013"},{"key":"key\n\t\t\t\t20171012192624_B56","doi-asserted-by":"crossref","unstructured":"Pournaras S, Ikonomidis A, Sofianou D et al. CTX-M-type \u03b2-lactamases affect community Escherichia coli treatment, Greece. Emerg Infect Dis2004; 10: 1163\u20134.","DOI":"10.3201\/eid1006.031031"},{"key":"key\n\t\t\t\t20171012192624_B57","doi-asserted-by":"crossref","unstructured":"Pitout JD, Laupland K, Church DL et al. Community-wide outbreaks of clonally related Escherichia coli producing CTX-M-14-\u03b2-lactamases in the Calgary Health Region (CHR). J Clin Microbiol2005; 43: in press.","DOI":"10.1128\/JCM.43.6.2844-2849.2005"},{"key":"key\n\t\t\t\t20171012192624_B58","doi-asserted-by":"crossref","unstructured":"Shiraki Y, Shibata N, Doi Y et al. Escherichia coli producing CTX-M-2 \u03b2-lactamase in cattle, Japan. Emerg Infect Dis2004; 10: 69\u201375.","DOI":"10.3201\/eid1001.030219"},{"key":"key\n\t\t\t\t20171012192624_B59","doi-asserted-by":"crossref","unstructured":"Carattoli A, Lovari S, Franco A et al. Extended-spectrum \u03b2-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother2005; 49: 833\u20135.","DOI":"10.1128\/AAC.49.2.833-835.2005"},{"key":"key\n\t\t\t\t20171012192624_B60","doi-asserted-by":"crossref","unstructured":"Baquero F. From pieces to patterns: evolutionary engineering in bacterial pathogens. Nat Rev Microbiol2004; 2: 510\u20138.","DOI":"10.1038\/nrmicro909"},{"key":"key\n\t\t\t\t20171012192624_B61","doi-asserted-by":"crossref","unstructured":"Poirel L, Lartigue MF, Decousser JW et al. ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli. Antimicrob Agents Chemother2005; 49: 447\u201350.","DOI":"10.1128\/AAC.49.1.447-450.2005"},{"key":"key\n\t\t\t\t20171012192624_B62","doi-asserted-by":"crossref","unstructured":"Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis2001; 7: 178\u201382.","DOI":"10.3201\/eid0702.010204"},{"key":"key\n\t\t\t\t20171012192624_B63","doi-asserted-by":"crossref","unstructured":"Lartigue MF, Poirel L, Decousser JW et al. Multidrug resistant Shigella sonnei and Salmonella enterica serotype Typhimurium isolates producing CTX-M \u03b2-lactamases as a source of community acquired infections. Clin Infect Dis2005; 40: 1069\u201370.","DOI":"10.1086\/428667"},{"key":"key\n\t\t\t\t20171012192624_B64","unstructured":"Bilal NE, Gedebou M. Clinical and community strains of Klebsiella pneumoniae: multiple and increasing rates of antibiotic resistance in Abha, Saudi Arabia. Br J Biomed Sci2000; 57: 185\u201391."},{"key":"key\n\t\t\t\t20171012192624_B65","doi-asserted-by":"crossref","unstructured":"Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis2000; 19: 112\u20137.","DOI":"10.1007\/s100960050440"},{"key":"key\n\t\t\t\t20171012192624_B66","doi-asserted-by":"crossref","unstructured":"Hryniewicz K, Szczypa K, Sulikowska A et al. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother2001; 47: 773\u201380.","DOI":"10.1093\/jac\/47.6.773"},{"key":"key\n\t\t\t\t20171012192624_B67","doi-asserted-by":"crossref","unstructured":"Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents2001; 18: 211\u20135.","DOI":"10.1016\/S0924-8579(01)00389-2"},{"key":"key\n\t\t\t\t20171012192624_B68","doi-asserted-by":"crossref","unstructured":"Einhorn AE, Neuhauser MM, Bearden DT et al. Extended-spectrum \u03b2-lactamases: frequency, risk factors, and outcomes. Pharmacotherapy2002; 22: 14\u201320.","DOI":"10.1592\/phco.22.1.14.33497"},{"key":"key\n\t\t\t\t20171012192624_B69","doi-asserted-by":"crossref","unstructured":"Tan BH, Tan AL. Community-acquired bacteremia with an ESBL-producing Escherichia coli strain\u2014a case report. Int J Infect Dis2002; 6: 318\u20139.","DOI":"10.1016\/S1201-9712(02)90168-2"},{"key":"key\n\t\t\t\t20171012192624_B70","unstructured":"Borer A, Gilad J, Menashe G et al. Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Med Sci Monit2002; 8: CR44\u2013CR47."},{"key":"key\n\t\t\t\t20171012192624_B71","doi-asserted-by":"crossref","unstructured":"Ozden M, Kalkan A, Demirdag K et al. Ciprofloxacin and co-trimoxazole resistance and extended spectrum \u03b2-lactamase production in Escherichia coli strains isolated from urinary tract infections. Int J Antimicrob Agents2003; 21: 492\u20133.","DOI":"10.1016\/S0924-8579(03)00042-6"},{"key":"key\n\t\t\t\t20171012192624_B72","doi-asserted-by":"crossref","unstructured":"Lee K, Yong D, Yum JH et al. Diversity of TEM-52 extended-spectrum \u03b2-lactamase-producing non-typhoidal Salmonella isolates in Korea. J Antimicrob Chemother2003; 52: 493\u20136.","DOI":"10.1093\/jac\/dkg385"},{"key":"key\n\t\t\t\t20171012192624_B73","doi-asserted-by":"crossref","unstructured":"Motta RN, Oliveira MM, Magalhaes PS et al. Plasmid-mediated extended-spectrum \u03b2-lactamase-producing strains of Enterobacteriaceae isolated from diabetes foot infections in a Brazilian diabetic center. Braz J Infect Dis2003; 7: 129\u201334.","DOI":"10.1590\/S1413-86702003000200006"},{"key":"key\n\t\t\t\t20171012192624_B74","doi-asserted-by":"crossref","unstructured":"Abdalhamid B, Pitout JD, Moland ES et al. Community-onset disease caused by Citrobacter freundii producing a novel CTX-M \u03b2-lactamase, CTX-M-30, in Canada. Antimicrob Agents Chemother2004; 48: 4435\u20137.","DOI":"10.1128\/AAC.48.11.4435-4437.2004"},{"key":"key\n\t\t\t\t20171012192624_B75","doi-asserted-by":"crossref","unstructured":"Dimitrov TS, Udo EE, Emara M et al. Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital. Med Princ Pract2004; 13: 334\u20139.","DOI":"10.1159\/000080470"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/1\/52\/2084878\/dki166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T08:10:40Z","timestamp":1683101440000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/1\/52\/706767\/Emergence-of-Enterobacteriaceae-producing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,25]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,5,25]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki166","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,7]]},"published":{"date-parts":[[2005,5,25]]}}}